Corridor Pharmaceuticals
Stage
Debt | DeadTotal Raised
$20.71MLast Raised
$1.55MAbout Corridor Pharmaceuticals
Corridor Pharmaceuticals, formerly Arginetix, is a platform-based pulmonary and critical care company focused on developing therapeutics to treat inflammation, fibrosis and endothelial dysfunction. Utilizing their platform technology, the Company has discovered a highly potent, small molecule approach to inhibiting arginase. Corridor is targeting diseases where elevated arginase levels have been shown to be involved in disease progression such a pulmonary fibrosis, COPD and ischemia reperfusion injury (IRI).
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Corridor Pharmaceuticals Patents
Corridor Pharmaceuticals has filed 1 patent.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/26/2011 | 11/25/2014 | Autosomal recessive disorders, Amino acids, Rare diseases, EC 1.14.13 | Grant |
Application Date | 7/26/2011 |
|---|---|
Grant Date | 11/25/2014 |
Title | |
Related Topics | Autosomal recessive disorders, Amino acids, Rare diseases, EC 1.14.13 |
Status | Grant |
Corridor Pharmaceuticals Frequently Asked Questions (FAQ)
Where is Corridor Pharmaceuticals's headquarters?
Corridor Pharmaceuticals's headquarters is located at 1122 Kenilworth Drive, Towson.
What is Corridor Pharmaceuticals's latest funding round?
Corridor Pharmaceuticals's latest funding round is Debt.
How much did Corridor Pharmaceuticals raise?
Corridor Pharmaceuticals raised a total of $20.71M.
Who are the investors of Corridor Pharmaceuticals?
Investors of Corridor Pharmaceuticals include Domain Associates, MedImmune Ventures, Quaker BioVentures, Red Abbey Venture Partners, Ben Franklin Technology Partners of Southeastern PA and 5 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
